Thursday, January 18, 2007 7:30:00 AM PDT | VentureDeal Staff
MA -- The Eisai Research Institute of
Boston announced the opening of its 150,000 square foot pharmaceutical
research facility. The facility was financed by its Japanese parent
company, Eisai Co., Ltd. and will consolidate basic discovery research and
provide for future company growth.
"The $65 million facility will be devoted to discovery research utilizing
a combination of natural products-based synthetic organic chemistry and target-
oriented biology to identify and develop drug compounds.
Two compounds discovered at the Eisai Research Institute are in phase III
clinical trials - one for severe sepsis and one for cancer.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
VentureDeal is a database that provides the latest information about venture capital firms, venture-backed technology companies and transactions throughout North America.
Learn More »
Email Sign Up
© 2014 VentureDeal, Inc., Menlo Park, CA. All Rights Reserved.